The IVI Establishment Agreement entered the United Nations Depository of Treaties under Chapter IX. On May 29, 1997, The IVI Establishment Agreement entered into force following the submission of instruments of ratification by South Korea, Sweden, and Uzbekistan. In 1997 more countries followed, with Brazil, China, Egypt, Israel, Jamaica, Kyrgyzstan, Myanmar, Nepal, Pakistan, Papua New Guinea, Peru, Sri Lanka, Sweden, Tajikistan, and Turkey signing the Agreement. Representatives of Bangladesh, Bhutan, Indonesia, Kazakhstan, Mongolia, the Netherlands, Panama, Republic of Korea, Romania, Thailand, Vietnam, Uzbekistan, and the WHO were the first to sign the agreement, followed shortly thereafter by Senegal and Philippines. On October 28, 1996, the IVI Establishment Agreement opened for signatures at the UN headquarters in New York City. In order to establish IVI as an independent international organization, the UNDP and Korean government elected to establish the institute through an intergovernmental agreement of UN member states, as sanctioned in the Vienna Convention on the Laws of Treaties of 1969. In 19, the UNDP and the South Korean government jointly developed the basic framework and Constitution of IVI. Signing of the IVI Establishment Agreement Foundation In 1995, UNDP opened an interim IVI office on the campus of Seoul National University and the Institute began its initial work and organizational development. In 1994, following a call for proposals to host IVI in the Asia Pacific region, the UNDP and the Republic of Korea reached an agreement to host the center in Seoul. īased on the results of Shin's feasibility study, in 1993 the UNDP adopted a formal proposal to establish the International Vaccine Institute (IVI). Seung-Il Shin, then Senior Health Advisor for the United Nations Development Programme (UNDP), initiated a study to explore the feasibility of establishing an international institute devoted to vaccine research and development within the framework of the Children's Vaccine Initiative (CVI). The institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions. Currently, IVI has 39 member states (33 signatories and 23 parties) and the World Health Organization (WHO) as signatories to its Establishment Agreement. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.Ĭreated initially as an initiative of the UN Development Programme (UNDP), IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea. The International Vaccine Institute ( IVI) is an independent, nonprofit, international organization founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |